Nu Skin Enterprises, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B |
| Cost of Revenue | $453.8M | $550.2M | $611.9M | $630.9M | $675.2M | $658.0M | $581.4M | $634.1M |
| Gross Profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B |
| Gross Margin | 69.4% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% |
| Operating Expenses | ||||||||
| Research & Development | $10.8M | $13.0M | $22.6M | $23.3M | $27.2M | $23.3M | $30.1M | $23.0M |
| SG&A Expense | $432.1M | $479.0M | $546.9M | $555.8M | $654.4M | $636.5M | $616.0M | $662.3M |
| Operating Income | $65.8M | $-151.6M | $48.3M | $110.8M | $234.0M | $257.6M | $267.4M | $240.9M |
| Operating Margin | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% | 10.0% | 11.0% | 9.0% |
| Interest Expense | — | — | $25.6M | $13.5M | $11.0M | $13.1M | $19.2M | $21.8M |
| Pretax Income | $196.2M | $-175.1M | $26.6M | $89.0M | $232.5M | $256.2M | $255.2M | $219.7M |
| Income Tax Expense | $36.0M | $-28.5M | $18.0M | $-15.8M | $85.2M | $64.9M | $81.6M | $97.8M |
| Net Income | $160.2M | $-146.6M | $8.6M | $104.8M | $147.3M | $191.4M | $173.6M | $121.9M |
| Net Margin | 10.8% | -8.5% | 0.4% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% |
| EPS (Basic) | $3.25 | $-2.95 | $0.17 | $2.10 | $2.93 | $3.66 | $3.13 | $2.21 |
| EPS (Diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 |
| Shares Outstanding (Basic) | 49.3M | 49.7M | 49.7M | 50.0M | 50.2M | 52.3M | 55.5M | 55.2M |
| Shares Outstanding (Diluted) | 50.3M | 49.7M | 49.9M | 50.5M | 51.4M | 52.8M | 55.9M | 56.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |